- Home
- CRVS vs RZLV Comparison
CRVS vs RZLV Comparison
Compare CRVS & RZLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- RZLV
- Stock Information
- Founded
- CRVS 2014
- RZLV 2016
- Country
- CRVS United States
- RZLV United Kingdom
- Employees
- CRVS N/A
- RZLV N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- RZLV
- Sector
- CRVS Health Care
- RZLV
- Exchange
- CRVS Nasdaq
- RZLV NYSE
- Market Cap
- CRVS 516.0M
- RZLV 526.2M
- IPO Year
- CRVS 2016
- RZLV N/A
- Fundamental
- Price
- CRVS $5.22
- RZLV $2.86
- Analyst Decision
- CRVS Strong Buy
- RZLV Strong Buy
- Analyst Count
- CRVS 5
- RZLV 4
- Target Price
- CRVS $12.38
- RZLV $5.50
- AVG Volume (30 Days)
- CRVS 1.6M
- RZLV 15.0M
- Earning Date
- CRVS 11-12-2024
- RZLV 02-21-2025
- Dividend Yield
- CRVS N/A
- RZLV N/A
- EPS Growth
- CRVS N/A
- RZLV N/A
- EPS
- CRVS N/A
- RZLV N/A
- Revenue
- CRVS N/A
- RZLV $145,051.00
- Revenue This Year
- CRVS N/A
- RZLV $244.80
- Revenue Next Year
- CRVS N/A
- RZLV $9,101.29
- P/E Ratio
- CRVS N/A
- RZLV N/A
- Revenue Growth
- CRVS N/A
- RZLV 25.96
- 52 Week Low
- CRVS $1.30
- RZLV $1.57
- 52 Week High
- CRVS $10.00
- RZLV $14.50
- Technical
- Relative Strength Index (RSI)
- CRVS 41.23
- RZLV N/A
- Support Level
- CRVS $4.60
- RZLV N/A
- Resistance Level
- CRVS $6.47
- RZLV N/A
- Average True Range (ATR)
- CRVS 0.39
- RZLV 0.00
- MACD
- CRVS 0.06
- RZLV 0.00
- Stochastic Oscillator
- CRVS 33.16
- RZLV 0.00
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About RZLV REZOLVE AI LTD
Rezolve AI Ltd provides a mobile commerce and engagement platform, underpinned by machine learning, that enables retailers, brands and manufacturers to engage with consumers in a broad range of locations and settings via their mobile devices and personal computers. its platform allows for mobile engagement with merchants using its software to extend their business to consumers' mobile devices and computers in different ways.